Light therapy gel targets skin cancer in final test phase
Disease control
Recruiting now
This study is testing whether a gel called HyBryte, which is activated by a special light, can help treat early-stage cutaneous T-cell lymphoma (CTCL), a type of skin cancer. About 80 participants will apply the gel or a placebo to their skin patches twice a week for 18 weeks, fo…
Phase: PHASE3 • Sponsor: Soligenix • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC